Objectives-To evaluate the effectiveness of shear wave elastography (SWE) for differentiating benign from malignant breast papillary lesions Methods-B-mode ultrasound (US) and SWE were available in 56 surgically confirmed papillary lesions (48 [85.7%] benign and 8 [14.3%] malignant). The diagnostic performances of US, SWE parameters, and combined US with SWE parameters were calculated by receiver operating characteristic curve analysis and compared.
lasticity imaging has emerged as a promising modality for improving the diagnostic accuracy for breast lesions. Recently, the American College of Radiology Breast Imaging Reporting and Data System (BI-RADS) added elasticity assessment using strain elastography or shear wave elastography (SWE) as an associated feature in the ultrasound (US) lexicon. 1 Static US elastography provides a color map of tissue elasticity superimposed on the B-mode US image, whereas SWE, which is induced by the radiation force of a focused US beam, can allow acquisition of objective and highly reproducible measurements of tissue stiffness by quantitative parameters. 2 Shear wave elastography is useful in differentiating benign and malignant breast lesions, and the addition of SWE to conventional US imaging improves the diagnostic performance for breast cancer with increased specificity. [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] The hypothesis applied for the clinical application of elasticity for breast lesions was that benign lesions tend to be harder than normal breast tissue but softer than cancers. 8, 13 Some previous studies reported that specific breast tumor types were soft and the causes of false-negative elastographic findings. 14, 15 Breast papillary cancer can be one of the specific tumor types, and if so, elasticity might be ineffective in differentiating benign and malignant breast papillary lesions, unlike normal breast lesions. However, Choi et al 16 reported that the strain elasticity scores for malignant breast papillary lesions were significantly higher than for benign lesions, and adding elasticity to conventional US imaging improved the specificity for papillary cancer diagnosis with US. However, their study had limitations in that papillary lesions without surgical excision were included, and static elasticity had no quantitative measurements. 16 Breast papillary lesions including a broad spectrum from benign papillomas to invasive papillary cancers are common, which proves challenging for characterizing benign and malignant lesions by clinical, imaging, and histopathologic findings. A few recent articles suggested that some US features might be helpful in differentiating benign and malignant breast papillary lesions, 17, 18 but the current thought is that the diagnostic accuracy of imaging modalities, including conventional US, is low, and surgical excision is required for definitive diagnosis of breast papillary lesions. Thus, determining any diagnostic features for characterizing benign and malignant breast papillary lesions is crucial for proper management.
To the best of our knowledge, there are no studies to date regarding the clinical application of SWE for breast papillary lesions. Therefore, the aim of this preliminary study was to retrospectively analyze the quantitative SWE values for surgically verified breast papillary lesions and to evaluate the effectiveness of SWE for differentiating benign from malignant breast papillary lesions.
Materials and Methods

Patients
An Institutional Review Board approved this retrospective study, and informed consent from patients was not required for the review of medical charts and US images. Through the pathologic database in our single university-affiliated institution from June 2012 to October 2015, we identified 171 breast papillary lesions in 165 women. Among them, 77 lesions were excluded because SWE was not applied, and both conventional grayscale US and SWE images were available in 94 lesions. Fifty-six of 94 were surgically excised, and the remaining 38 were followed by US (n 5 30) or rebiopsied with vacuum-assisted removal (n 5 8). Finally, 56 lesions in 54 women were enrolled in this study. One woman underwent surgical excision for 3 papillary lesions. Thirty-three lesions (58.9%) were asymptomatic, whereas the remaining 23 (41.1%) were symptomatic (palpability in 13, nipple discharge in 9, and pain in 1).
Ultrasound Examinations
The breast US examinations were performed with an Aixplorer US system (SuperSonic Imagine, Ax-enProvence, France), equipped with a 4-15-MHz linear array transducer, by 1 of 3 radiologists with 7 to 13 years of experience in breast US and at least 1 month of experience in performing SWE before enrolling the first participant. All radiologists were informed of the clinical information and mammographic findings at the time of the US examinations. Each breast lesion detected on US imaging was recorded, with the lesion's longest diameter, distance from the nipple, location, and US features, including shape, margin, echogenicity, and lesion type, and was finally assessed by BI-RADS categorization. A complex cystic or intraductal lesion was categorized as BI-RADS category 4A or higher. After B-mode US, SWE images were obtained by applying the linear transducer very lightly to the skin above the targeted lesion. The transducer was held for a few seconds until the SWE image was stabilized, and an image with adequate quality that simultaneously displayed the corresponding grayscale US image was saved in the split-screen mode. When a lesion was complex cystic, or intraductal, the SWE image was set only for a solid area within the lesion. The region of interest box (Q-box; SuperSonic Imagine) was set to include the lesion and the surrounding normal tissue. Tissue elasticity was represented by a semitransparent color map overlaid on the grayscale image with a range from dark blue, indicating the lowest stiffness, to red, indicating the highest stiffness (0-180 kPa by the Young's modulus). A fixed 2 3 2-mm region of interest was placed by an investigator over the stiffest part of the lesion, including immediately adjacent stiff tissue, and another region of interest of the same size was placed in the normal fatty tissue (Figure 1 ). The system automatically calculated and showed the maximum elasticity, minimum elasticity, mean elasticity, ratio between the mean elasticity values in the lesion and in the fat, and standard deviation of both region of interest boxes on the SWE image (Figure 1 ).
Image Evaluation
Each grayscale US image was retrospectively reviewed by a certificated radiologist with 11 years of experience in breast imaging who was blinded to clinical, mammographic, and pathologic findings. The lesion size, distance from the nipple, lesion location, and lesion type (eg, complex cystic or intraductal) were evaluated from representative radial and antiradial planes for each lesion. If the lesion was located within the duct, length of the duct segment that contained the mass or debris, size and intraductal location of the mass, presence of vascularity, clock face position, and distance from the nipple were evaluated. A final assessment was assigned for each lesion according to the BI-RADS US categories. In reviewing SWE images, only quantitative information, including maximum elasticity, mean elasticity, elasticity ratio, and standard deviation, was analyzed.
Pathologic Analyses
The pathologic results were classified as either benign papillary lesions, such as intraductal papilloma, sclerotic papilloma, atypical papilloma, and papillomatosis, or malignant papillary lesions, such as invasive papillary carcinoma, papillary carcinoma in situ, and intraductal or intracystic papillary cancer. Benign papillary lesions at core biopsy were managed regardless of imaginghistologic concordance and recommended for subsequent surgical excision in our institution.
Data Analyses
For each lesion, clinical, imaging, and pathologic variables were recorded in an Excel spreadsheet (Microsoft Corporation, Redmond, WA). Variables included patient age, lesion size, symptom, distance from the nipple, lesion type, such as intraductal or not, BI-RADS category, core biopsy pathologic results, surgical excision pathologic results, and SWE quantitative parameters (maximum elasticity, mean elasticity, elasticity ratio, and standard deviation). For data analyses, surgical excisional findings were used as the reference standard. BI-RADS US category 3 was considered negative, and categories 4A and higher were considered positive.
Combined US and Quantitative SWE Parameters for BI-RADS 4A Lesions If a lesion with BI-RADS category 4A had an SWE quantitative parameter of less than the cutoff value, it was downgraded to BI-RADS 3; if a lesion with BI-RADS category 3 had a SWE quantitative parameter equal to or higher than the cutoff value, it was upgraded to BI-RADS category 4A; and lesions with BI-RADS category 4B and higher were not downgraded with SWE quantitative analysis.
Statistical Analyses
Quantitative SWE features were compared between benign and malignant lesions by the nonparametric Fisher exact test for categorical variables and the MannWhitney test for continuous variables. The KolmogorovSmirnov test was used for normality of the continuous variables. To evaluate the diagnostic performance of US and each SWE parameter for differentiating benign and malignant papillary lesions, we calculated and compared the area under the receiver operating characteristic curve (A z ). The optimal cutoff value with the best diagnostic performance was obtained for each quantitative SWE parameter. The A z values for combined US and SWE parameters using the obtained optimal cutoff values were also calculated and compared with that of US alone. Statistical analyses were performed with the SPSS version 20.0 software package (IBM Corporation, Armonk, NY) and MedCalc version 14.10.2, (MedCalc Software, Mariakerke, Belgium). All tests were 2 sided, and a significant difference was determined as P < .05.
Results
General Characteristics of Breast Papillary Lesions
The mean age 6 SD of the 54 included women was 40.76 6 8.07 years (range, 21-71 years. Of the 56 papillary lesions, 48 (85.7%) were benign, and 8 (14.3%) were malignant. The pathologic types of all lesions were confirmed by surgical excision. The pathologic details were as follows: intraductal papilloma (n 5 41), atypical papilloma or papilloma with atypical ductal hyperplasia (n 5 7), intraductal papillary cancer (n 5 6), and invasive papillary cancer (n 5 2). The mean size of the 48 benign papillary lesions was 17. Data are presented as average 6 SD (range). Figure 2A) . The optimal cutoff values that produced the maximal sensitivity and specificity for other parameters are listed in Table 3 . The A z values of all SWE parameters were higher than that of B-mode US, with statistical significance for the mean elasticity, maximum elasticity, and elasticity ratio (P < .01; P 5 .03; and P 5 .0499, respectively). Figure 2 . A, Receiver operating characteristic curves for SWE parameters. B, Receiver operating characteristic curves for US and combined parameters.
downgraded to category 3 for all SWE parameters. The A z values for combined US and SWE parameters are summarized in Table 3 , and Figure 2B shows their receiver operating characteristic curves. 
Discussion
The lesion stiffness measured by quantitative SWE of our 8 papillary cancers was not as much as that of common breast cancers. The 2 invasive papillary cancers showed average values of 73.8 kPa for mean elasticity, 78.0 kPa for maximum elasticity, 18.6 kPa for elasticity ratio, and 5.1 for SD and corresponded relatively to the results of the prior studies. 19, 20 In a study by Chang et al, 19 the mean elasticity value of 6 invasive papillary cancers was 88.7 kPa, whereas the mean elasticity value of the other 331 cancers (298 ductal, 7 mixed ductal and lobular, 16 lobular, 3 mucinous, 1 medullary, 2 apocrine, and 4 metaplastic) ranged from 116.7 to 182.9 kPa. Additionally, a study by Evans et al 20 also showed mean elasticity values of 87 kPa in 4 invasive papillary cancers, and 142 to 186 kPa in 84 ductal and 7 lobular cancers. For our 6 intraductal papillary cancers, average SWE values were 44.7 kPa for mean elasticity, 48.1 kPa for maximum elasticity, 7.2 kPa for elasticity ratio, and 2.7 for SD. Two among 6 had very low stiffness, with mean elasticity values of 28.5 and 25.3 kPa, and 1 of the 2 lesions was falsely downgraded to benign by integration into BI-RADS category 4A according to the parameters' cutoff values, resulting in a false-negative result. Meanwhile, SWE values for ductal carcinoma in situ were reported from 69.6 to 117.8 kPa for mean elasticity in previous studies. 10, 19 According to the prior results 10, 19, 20 and ours, breast papillary cancers are less stiff than other breast cancers, ranging from 25.3 to 88.7 kPa. Meanwhile, according to Kim et al, 9 the average mean elasticity values for chronic inflammation (73.4 kPa [n 5 8]) and intraductal papillomas (51.8 kPa [n 5 13]) were relatively high compared with those for benign breast lesions, and other studies also reported high mean elasticity values ranging from 69.5 to 187.3 kPa for benign papillary lesions. 10, 19 However, our 41 benign papillomas had an average mean elasticity value of 35.8 kPa, and 7 atypical papillomas had an average value of 46.8 kPa. In this study, the elasticity values for benign papillary lesions were lower than in the prior studies and were similar to those of other benign breast masses. However, because our papillary cancers were not stiff enough, none of the average values showed significant differences between benign and malignant papillary lesions.
With regard to the optimal cutoff value for differentiating between benign and malignant breast masses, in a study of 156 breast masses (120 benign and 36 malignant) by Lee et al, 10 the optimal cutoff values were 68.4 kPa for mean elasticity, 82.3 kPa for maximum elasticity, 4.39 for elasticity ratio, and 9.6 for SD, with the highest A z (0.860) for maximum elasticity. Chang et al 6 also had an optimal cutoff mean elasticity value of 80.17 kPa with also reported that using a cutoff value of 50 kPa for the mean elasticity of 53 masses (30 malignant and 23 benign), the sensitivity and specificity were 97%, 83%, respectively. Our study determined optimal SWE cutoff values of 44.3 kPa for mean elasticity, 48.5 kPa for maximum elasticity, 2.5 for elasticity ratio, and 3.3 for SD for breast papillary lesions, and the performance for mean elasticity was the highest. Our optimal cutoff value was lower than those of prior studies 6,7,10 because breast papillary cancers are less stiff than other breast cancers.
More recent studies have concluded that the addition of SWE parameters to BI-RADS category 4A lesions on B-mode US imaging improved diagnostic performance. 4, 5, 9, 11, 12 Berg et al 5 reported that adding SWE to BI-RADS feature analysis improved the specificity, from 61.1% (397 of 650) to 78.5% (510 of 650; P < .001), of breast US mass evaluation. According to Youk et al, 12 in their study of 389 breast masses (269 benign and 120 malignant), an elasticity ratio of 5.14 was the optimal cutoff value with the highest A z (0.952), and the A z for combined studies was significantly higher than that for conventional US or SWE. Although adding SWE reportedly improved the diagnostic performance of conventional US for the evaluation of the breast masses, the performance of B-mode US alone was also good (A z values, 0.915-0.970). 4, 5, 9, 11, 12 However, because papillary lesions have a wide morphologic spectrum, it is not yet feasible to differentiate between benign and malignant lesions by US features. Therefore, as expected, our study showed very low performance of B-mode US for papillary lesions, particularly with specificity of 0%; thus, false-positive biopsy results were obtained in 48 of 56 lesions (85.7%). By adding the mean elasticity value to BI-RADS assessment in this study, 33 (75%) of 44 category 4A lesions were correctly downgraded. The falsepositive biopsy rate could be significantly reduced to 15 (26.8%) of 56. Therefore, according to our results, the addition of an optimal mean elasticity cutoff value of 44.3 kPa to B-mode US could improve the performance of SWE and the very low specificity of B-mode US for breast papillary lesions as well, with a significant decrease in the false-positive biopsy rate. However, whereas 33 unnecessary biopsies (58.9%) were reduced by adding the optimal cutoff value to the BI-RADS assessment, 1 intraductal papillary cancer with 25.3 kPa for mean elasticity was falsely downgraded. Unfortunately, a decrease in the false-positive biopsy rate carries a risk of an increase in false-negative results. If we used a mean elasticity cutoff value of less than 25.3 kPa, there could have been no false-negative downgrades, but that conservative strategy would have resulted in 25 false-positive biopsy results (44.6%). It is not simple to set a cutoff value for minimizing unnecessary biopsies or missed cancers. As is well known, US has risks of false-positive results and unnecessary biopsies that may outweigh the scans' benefits, and additionally, US showed extremely low specificity for differentiating breast papillary lesions in this study. The downgraded category 3 lesion will be followed in 6 months, and missed cancers have a favorable prognosis that is equivalent to that of cancers detected by screening. Therefore, although 1 missed cancer was created, we suggest that using a mean elasticity cutoff value of 44.3 kPa is an optimal application.
There were some limitations in our study. First, this preliminary study was a retrospective study including small numbers of papillary lesions. This factor would limit the application of SWE criteria for papillary lesions. Large-scale prospective studies might be necessary to verify our results. Second, 1 of 3 radiologists performed B-mode US examinations and independently evaluated SWE for the lesions, and there could have been interobserver variability. However, SWE has been reported as a highly reproducible method, 2 so interobserver variability was expected to have little influence on our results.
In conclusion, SWE was useful for differentiating benign and malignant breast papillary lesions, and the addition of SWE parameter cutoff values to B-mode US was effective for increasing the performance of B-mode US, with a significant decrease in the false-positive biopsy rate.
